RTTNews | May 20, 2021 10:27AM EDT

10:26 Thursday, May 20, 2021 (RTTNews.com) - Innoviva Inc. (INVA) agreed to repurchase of GSK's equity stake in Innoviva, constituting about 32 million shares, or 32% of the outstanding common stock, at $12.25 per shar for a total purchase price of $392 million.

The purchase price represents a 3% discount to the 5-day volume weighted average price of Innoviva's common stock.

Innoviva noted that GSK was its largest shareholder for many years and remains a key commercial partner.'

In Thursday regular trade, INVA was trading at $12.80 up $0.51 or 4.11%.

Read the original article on RTTNews ( https://www.rttnews.com/3196466/innoviva-to-repurchase-gsk-s-32-stake-in-company-for-392-mln.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved